ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
Grupo Espanol de Investigacion en Sarcomas
OHSU Knight Cancer Institute
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
OHSU Knight Cancer Institute
GlaxoSmithKline
National Cancer Institute (NCI)